Search
Nanjing Veriscience Biotech Applies for Listing on Hong Kong Stock Exchange
2025-06-04 /
Read about 0 minute
Author：小编
Nanjing Veriscience Biotech Co., Ltd. has officially submitted an application for listing on the Hong Kong Stock Exchange, with Morgan Stanley and CITIC Securities acting as joint sponsors. The company is dedicated to the research and development of innovative therapies aimed at addressing the medical needs associated with major diseases, including cancer and autoimmune disorders.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
